"Uncovering Scientific Misconduct: The Downfall of Psychiatry's Antidepressant Claims"

The effectiveness of antidepressant drugs has long been a topic of debate, with recent revelations of scientific misconduct and fraud in the STAR*D study, which claimed a 67% remission rate for patients with major depressive disorder. The reanalysis of the study revealed that the actual remission rate was only 35%, leading to concerns about the harm caused by inflated results. This has prompted a reevaluation of standard antidepressant treatments and a call for psychiatry to address the significant differences in remission rates, potentially marking a setback for the field.